Peak Asset Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.05M | Sell |
17,035
-838
| -5% | -$96.7K | 0.36% | 56 |
|
|
2025
Q4 | $1.88M | Sell |
17,873
-372
| -2% | -$34.9K | 0.32% | 59 |
|
|
2025
Q3 | $1.53M | Sell |
18,245
-825
| -4% | -$68K | 0.27% | 63 |
|
|
2025
Q2 | $1.51M | Buy |
19,070
+743
| +4% | +$59.1K | 0.28% | 66 |
|
|
2025
Q1 | $1.65M | Buy |
18,327
+695
| +4% | +$64.9K | 0.31% | 60 |
|
|
2024
Q4 | $1.75M | Buy |
17,632
+590
| +3% | +$60.8K | 0.32% | 58 |
|
|
2024
Q3 | $1.94M | Sell |
17,042
-867
| -5% | -$103K | 0.36% | 56 |
|
|
2024
Q2 | $2.22M | Sell |
17,909
-1,021
| -5% | -$132K | 0.43% | 46 |
|
|
2024
Q1 | $2.5M | Sell |
18,930
-1,366
| -7% | -$168K | 0.49% | 45 |
|
|
2023
Q4 | $2.21M | Buy |
20,296
+128
| +0.6% | +$13.3K | 0.49% | 48 |
|
|
2023
Q3 | $2.08M | Buy |
20,168
+275
| +1% | +$29.6K | 0.5% | 48 |
|
|
2023
Q2 | $2.3M | Buy |
19,893
+94
| +0.5% | +$10.7K | 0.53% | 46 |
|
|
2023
Q1 | $2.11M | Sell |
19,799
-93
| -0.5% | -$10K | 0.51% | 46 |
|
|
2022
Q4 | $2.21M | Sell |
19,892
-30
| -0.2% | -$3.07K | 0.58% | 40 |
|
|
2022
Q3 | $1.72M | Buy |
19,922
+135
| +0.7% | +$12.1K | 0.49% | 44 |
|
|
2022
Q2 | $1.8M | Sell |
19,787
-230
| -1% | -$20.4K | 0.49% | 45 |
|
|
2022
Q1 | $1.64M | Buy |
20,017
+1,113
| +6% | +$87.8K | 0.38% | 51 |
|
|
2021
Q4 | $1.45M | Buy |
18,904
+250
| +1% | +$19.9K | 0.33% | 55 |
|
|
2021
Q3 | $1.4M | Buy |
18,654
+48
| +0.3% | +$3.65K | 0.35% | 53 |
|
|
2021
Q2 | $1.45M | Sell |
18,606
-1,267
| -6% | -$94.2K | 0.36% | 49 |
|
|
2021
Q1 | $1.46M | Buy |
19,873
+304
| +2% | +$22.4K | 0.35% | 51 |
|
|
2020
Q4 | $1.53M | Buy |
19,569
+154
| +0.8% | +$11.8K | 0.4% | 49 |
|
|
2020
Q3 | $1.54M | Sell |
19,415
-145
| -0.7% | -$11.4K | 0.46% | 47 |
|
|
2020
Q2 | $1.44M | Buy |
19,560
+4,234
| +28% | +$319K | 0.46% | 43 |
|
|
2020
Q1 | $1.13M | Sell |
15,326
-1,612
| -10% | -$127K | 0.43% | 45 |
|
|
2019
Q4 | $1.47M | Buy |
16,938
+582
| +4% | +$47.8K | 0.45% | 43 |
|
|
2019
Q3 | $1.31M | Sell |
16,356
-135
| -0.8% | -$10.8K | 0.43% | 46 |
|
|
2019
Q2 | $1.32M | Sell |
16,491
-413
| -2% | -$31.6K | 0.43% | 48 |
|
|
2019
Q1 | $1.34M | Sell |
16,904
-1,560
| -8% | -$117K | 0.46% | 46 |
|
|
2018
Q4 | $1.35M | Sell |
18,464
-1,586
| -8% | -$112K | 0.51% | 45 |
|
|
2018
Q3 | $1.36M | Sell |
20,050
-225
| -1% | -$14.3K | 0.46% | 44 |
|
|
2018
Q2 | $1.17M | Sell |
20,275
-58
| -0.3% | -$3.27K | 0.43% | 44 |
|
|
2018
Q1 | $1.06M | Buy |
20,333
+1,621
| +9% | +$87.5K | 0.39% | 46 |
|
|
2017
Q4 | $1M | Buy |
18,712
+2,433
| +15% | +$135K | 0.37% | 49 |
|
|
2017
Q3 | $995K | Sell |
16,279
-4
| -0% | -$243 | 0.36% | 54 |
|
|
2017
Q2 | $996K | Buy |
16,283
+1,134
| +7% | +$69K | 0.37% | 52 |
|
|
2017
Q1 | $918K | Sell |
15,149
-753
| -5% | -$45.7K | 0.35% | 57 |
|
|
2016
Q4 | $893K | Sell |
15,902
-262
| -2% | -$15.3K | 0.36% | 57 |
|
|
2016
Q3 | $963K | Hold |
16,164
| – | – | 0.4% | 56 |
|
|
2016
Q2 | $889K | Hold |
16,164
| – | – | 0.39% | 54 |
|
|
2016
Q1 | $816K | Buy |
16,164
+262
| +2% | +$12.8K | 0.39% | 51 |
|
|
2015
Q4 | $801K | Buy |
15,902
+2,022
| +15% | +$102K | 0.39% | 43 |
|
|
2015
Q3 | $654K | Buy |
13,880
+796
| +6% | +$42.3K | 0.35% | 49 |
|
|
2015
Q2 | $711K | Sell |
13,084
-4,686
| -26% | -$263K | 0.37% | 50 |
|
|
2015
Q1 | $975K | Buy |
17,770
+239
| +1% | +$13.5K | 0.48% | 40 |
|
|
2014
Q4 | $950K | Buy |
+17,531
| New | +$977K | 0.5% | 42 |
|
Other funds holding MRK
VCM
VPM
Peak Asset Management's MRK Position: Q1 2026 in Review
Peak Asset Management reduced its Merck (MRK) stake by 4.7% in Q1 2026, selling an estimated $96.7K and leaving 17,035 shares worth $2.05M. The position accounts for 0.36% of the portfolio, ranked #56.
Peak Asset Management first reported a position in MRK in Q4 2014 and has held it in 46 quarters since. The position peaked at $2.5M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Peak Asset Management held 17,035 shares of Merck worth $2.05M as of Q1 2026.
- Peak Asset Management sold 838 Merck shares in Q1 2026, an estimated $96.7K.
- Merck made up 0.36% of Peak Asset Management's portfolio in Q1 2026, its #56 holding.
- Peak Asset Management first reported a position in Merck in Q4 2014 and has held it in 46 quarters since.
- Peak Asset Management's Merck position peaked at $2.5M in Q1 2024.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Peak Asset Management's 13F filing for Q1 2026, filed 15 May 2026.